Hepatozellulares Karzinom

Semela, D. and Heim, M.. (2011) Hepatozellulares Karzinom. Therapeutische Umschau, Vol. 68, H. 4. pp. 213-217.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6338552

Downloads: Statistics Overview


HCC is the fifth most common tumor worldwide and the third cause of cancer-related deaths. The incidence of HCC is increasing. HCC has become the leading cause of death in patients with liver cirrhosis. Surveillance of patients with chronic liver disease allows early detection of HCC. Surgical resection, liver transplantation and ablative therapies can cure early stage HCC. HCC of intermediate and advanced stage can be treated by chemoembolisation and the tyrosine kinase inhibitor sorafenib, respectively, leading to improved survival. This review summarizes the recent diagnostic and therapeutic developments in the field of HCC.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Hepatology Laboratory (Heim)
UniBasel Contributors:Heim, Markus H.
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Hans Huber
Note:Variant title: Hepatocellular carcinoma -- Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:10 Apr 2015 09:14
Deposited On:10 Apr 2015 09:14

Repository Staff Only: item control page